Issue Date: October 15, 2012
Roche Pact Pursues Hearing Loss Drugs
Roche has joined with Inception Sciences and the private equity firm Versant Ventures to create a drug discovery incubator, Inception 3, that will seek treatments for sensorineural hearing loss. The collaboration will pursue drugs that target inner ear hair cell protection and regeneration in the cochlea. It will draw on technology from Stanford University.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society